Intrasense

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets 12:30:18 17/07/2024 pm IST			5-day change	1st Jan Change
0.279 ^EUR	-0.36%		+0.72%	-22.50%

10/06	Intrasense: participation in the SIRM congress in Milan	CF
17/04	Intrasense: an innovative solution for cancer monitoring	CF

Intrasense: ambitions and publication calendar for 2022

January 24, 2022 at 10:44 pm IST

Intrasense: ambitions and publication calendar for 2022

24 Jan 2022 17:51 CET

Company Name

INTRASENSE

ISN

FR0011179886

Market

Euronext Growth

Symbol

ALINS

prambitions-calendrierjanvier-2022finaleng.pdf

Source

INTRASENSE

Provider

Euronext

Attachments

Original Link
Original Document
Permalink

Disclaimer

Intrasense SA published this content on 24 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 January 2022 17:13:06 UTC.

Latest news about Intrasense

Intrasense: participation in the SIRM congress in Milan	10/06	CF
Intrasense: an innovative solution for cancer monitoring	17/04	CF
Guerbet: CE certificate for a platform	09/04	CF
Intrasense: awarded CE certificate	09/04	CF
Invest Securities Raises Intrasense PT, Maintains Neutral Rating	22/03	MT
INTRASENSE : Invest Securities adjusts its target	22/03	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
CAC40: gloomy end to the week, timid weekly gain (+0.7%)	09/02	CF
Intrasense: 2023 sales down on China	09/02	CF
Guerbet: sales growth of 4% by 2023	09/02	CF
Intrasense Partners with Software Company EDL for Myrian Distribution	19/23/19	MT
Intrasense S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15	CI
Invest Securities Downgrades Intrasense to Neutral from Buy	04/23/04	MT
INTRASENSE : Invest Securities downgrades its recommendation	04/23/04	CF
Guerbet wins prostate cancer challenge	17/23/17	CF
Guerbet: agreement on AI for medical imaging	19/23/19	CF
Intrasense: joins Guerbet Group following successful takeover bid	12/23/12	CF
Guerbet: Intrasense joins the group	12/23/12	CF
Guerbet: holds 56.5% of Intrasense following reopening of its offer	09/23/09	CF
Guerbet SA completed the acquisition of 17.82% stake in Intrasense SA.	05/23/05	CI
Global markets live: Micron, Qantas, Zoom, Meta, BT Group...	23/23/23
Guerbet: takeover bid for Intrasense to resume on May 23	22/23/22	CF
Guerbet: successful takeover bid for Intrasense	22/23/22	CF
Guerbet: takeover bid opened for Intrasense shares	06/23/06	CF
Guerbet: AMF gives the green light to the takeover bid for Intrasense	05/23/05	CF

Chart Intrasense

Duration

Period

More charts

Company Profile

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1,200 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner...). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system.

Sector

Advanced Medical Equipment & Technology

Calendar

25/09/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTRASENSE	-22.50%	1.6Cr
THERMO FISHER SCIENTIFIC	+4.64%	21TCr
DANAHER CORPORATION	+8.99%	19TCr
INTUITIVE SURGICAL, INC.	+29.83%	16TCr
BOSTON SCIENTIFIC CORPORATION	+35.17%	11TCr
SIEMENS HEALTHINEERS AG	+1.75%	6.55TCr
EDWARDS LIFESCIENCES CORPORATION	+15.06%	5.29TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	4.53TCr
AGILENT TECHNOLOGIES, INC.	-2.14%	3.97TCr
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	3.77TCr

Other Advanced Medical Equipment & Technology